News | May 13, 2024
Briefs: Lupin and Aurobindo Pharma
Lupin updates on shipment of Mirabegron ER Tablets
Lupin updates on shipment of Mirabegron ER Tablets
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Investing in Malaysia's largest clinic operator to expand the healthcare business
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
Subcutaneous nivolumab has potential to be the first and only subcutaneously administered PD-1 inhibitor
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
ORACEA is a trademark of Galderma Holdings, S.A.
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
Subscribe To Our Newsletter & Stay Updated
